Abstract
The [tris(pyrazolyl)methane]ruthenium complexes [(K3-tpm) RuCl(solv)2]PF6 [tpm = tris(pyrazolyl)methane; solv = MeCN, dmso] and [(K3-tpm)RuCl(LL)]PF6 [LL = K 2-dppe, K2-dppp, K2-dppb, (PMePh 2)2] have been prepared, characterized and screened in vitro for their antiproliferative properties against the MCF-7 (breast) and HeLa (cervical) cancer cell lines by using the MTT assay. Although the MeCN and dmso complexes showed no activity under the conditions used, the phosphane complexes exhibited remarkable cytotoxic behaviour.
| Original language | English |
|---|---|
| Pages (from-to) | 4629-4633 |
| Number of pages | 5 |
| Journal | European Journal of Inorganic Chemistry |
| Issue number | 31 |
| DOIs | |
| Publication status | Published - Nov 2009 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anticancer agents
- Antiproliferative assays
- Half-sandwich complexes
- Ruthenium
- Tris(pyrazolyl)methane
Fingerprint
Dive into the research topics of '[Tris(pyrazolyl)methane]ruthenium complexes capable of inhibiting cancer cell growth'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver